PNC Financial Services Group
PRQR icon

PNC Financial Services Group’s ProQR Therapeutics PRQR Stock Holding History

PNC Financial Services Group’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-20,097
Closed -$40.6K – 5286
2025
Q4 		$40.6K Buy
20,097
+570
+3% +$1.33K ﹤0.01% 3327
2025
Q3 		$41.6K Buy
19,527
+1,878
+11% +$4.1K ﹤0.01% 3312
2025
Q2 		$36K Sell
17,649
-9,010
-34% -$14.7K ﹤0.01% 3293
2025
Q1 		$35.5K Sell
26,659
-2,244
-8% -$4.78K ﹤0.01% 3276
2024
Q4 		$76.6K Buy
+28,903
New +$91.8K ﹤0.01% 2845

Other funds holding PRQR

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PNC Financial Services Group's PRQR Position: Q1 2026 in Review

PNC Financial Services Group sold out of ProQR Therapeutics (PRQR) in Q1 2026, closing a stake of 20,097 shares — an estimated $40.6K sold.

PNC Financial Services Group first reported a position in PRQR in Q4 2024 and held it in 5 quarters. The position peaked at $76.6K in Q4 2024. 69 funds tracked by Wall St. Rank hold PRQR as of Q1 2026.

  • PNC Financial Services Group reported no remaining ProQR Therapeutics position as of Q1 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 20,097 ProQR Therapeutics shares in Q1 2026, an estimated $40.6K.
  • PNC Financial Services Group first reported a position in ProQR Therapeutics in Q4 2024 and held it in 5 quarters.
  • PNC Financial Services Group's ProQR Therapeutics position peaked at $76.6K in Q4 2024.
  • 69 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q1 2026.

Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.